by David Eyre | Jun 10, 2025 | UPC
The jurisprudence of the United Patent Court (UPC) is relatively new. Thus, a question of ongoing interest is to what extent the UPC will follow the jurisprudence of the European Patent Office (EPO) and/or one of the UPC member states was not fully known. The...
by Carolyn Haywood | May 1, 2025 | US & International
The subject CJEU referral stems from an action brought before the Swedish national court by BSH Hausgeräte GmbH (‘BSH’) against Electrolux AB (‘Electrolux’) seeking an injunction and damages with respect to the unlawful use of their invention protected by European...
by Alyson Lam | Mar 17, 2025 | UK
Background of Supplementary Protection Certificates (SPCs) SPCs are heavily relied on by pharmaceutical companies to extend the period of patent protection. Under the current regulations, SPCs can only be granted if the product is: 1) protected by a basic patent in...
by Luke Pettit | Jan 2, 2025 | EPO
Background and First Instance Decisions In Europe, claims directed toward mathematical methods are allowable only if it is clear that they contribute to the “technical character” of an invention. Under European practice, to assess the inventive step of a mathematical...
by David Eyre | Dec 6, 2024 | Uncategorised
Haemophilia B A blot clot is produced following a cascade of reactions after injury. Haemophilia is a disorder of blood clotting whereby one of the factors that contributes to this cascade of reactions is defective. Consequently, for sufferers from this condition...
Recent Comments